NeuroPace (NPCE) EBT Margin (2020 - 2026)
NeuroPace (NPCE) posted EBT Margin of 26.98% for Q2 2026, up 8.73% on a QoQ basis from 29.56% in Q1 2026, and up 2189.0% year-over-year from 1.18% in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) EBT Margin (2020 - 2026) Analysis & Trends
NeuroPace has reported EBT Margin for 7 years, with the latest figure at 26.98% in Q2 2026.
- On a quarterly basis, EBT Margin rose 2189.0% year-over-year to 26.98% in Q2 2026; TTM through Jun 2026 was 19.21%, a 1257.0% increase from a year earlier, with the FY2025 full-year figure at 20.98%, up 1336.0% from the prior year.
- EBT Margin was 26.98% for Q2 2026 at NeuroPace, up from 29.56% in the prior quarter.
- The five-year high for EBT Margin was 10.26% in Q4 2025, with the low at 123.58% in Q2 2022.
- Average EBT Margin over 5 years is 50.87%, with a median of 42.26% recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 7308 bps in 2022, then surged 6758 bps in 2023.
- Over 5 years, EBT Margin stood at 86.01% in 2022, then surged by 58 bps to 35.89% in 2023, then surged by 33 bps to 24.06% in 2024, then surged by 57 bps to 10.26% in 2025, then tumbled by 163 bps to 26.98% in 2026.
- The last three EBT Margin figures came in at 26.98% (Q2 2026), 29.56% (Q1 2026), and 10.26% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.32% |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | -26.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.98% |
| Mar 31, 2026 | -29.56% |
| Dec 31, 2025 | -10.26% |
| Sep 30, 2025 | -13.08% |
| Jun 30, 2025 | -48.87% |
| Mar 31, 2025 | -28.89% |
| Dec 31, 2024 | -24.06% |
| Sep 30, 2024 | -26.93% |
| Jun 30, 2024 | -39.64% |
| Mar 31, 2024 | -49.53% |
| Dec 31, 2023 | -35.89% |
| Sep 30, 2023 | -44.88% |
| Jun 30, 2023 | -56.00% |
| Mar 31, 2023 | -66.04% |
| Dec 31, 2022 | -86.01% |
| Sep 30, 2022 | -104.71% |
| Jun 30, 2022 | -123.58% |
| Mar 31, 2022 | -100.74% |
| Dec 31, 2021 | -97.22% |
| Sep 30, 2021 | -76.73% |